(SLAB) Silicon Laboratories - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8269191024
Stock: Microcontrollers, Sensors, IoT, Wireless, Mixed-Signal
Total Rating 63
Risk 88
Buy Signal -0.87
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 47.4% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 14.43 |
| Character TTM | |
|---|---|
| Beta | 1.733 |
| Beta Downside | 2.106 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.35% |
| CAGR/Max DD | 0.07 |
Description: SLAB Silicon Laboratories January 09, 2026
Silicon Laboratories (NASDAQ: SLAB) is a fabless semiconductor firm that designs analog-intensive mixed-signal solutions, notably wireless microcontrollers and sensor products, for a broad spectrum of industrial and commercial IoT applications-from smart-home cameras and HVAC controls to electric-vehicle charging stations and medical wearables.
In its most recent fiscal year (2023) the company reported revenue of roughly $1.0 billion, a year-over-year increase of about 10 % driven by strong demand for low-power connectivity chips in the industrial IoT segment; gross margins stayed near 55 % while operating cash flow exceeded $300 million, reflecting disciplined cost management. Key macro drivers include the U.S. CHIPS Act-funded expansion of domestic semiconductor capacity and the accelerating adoption of 5G-enabled edge devices, both of which underpin the long-term growth outlook for mixed-signal components.
If you’re looking to deepen your quantitative analysis, a quick look at ValueRay’s detailed valuation models for SLAB could surface additional upside scenarios worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -64.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 7.19 > 1.0 |
| NWC/Revenue: 67.57% < 20% (prev 86.27%; Δ -18.70% < -1%) |
| CFO/TA 0.08 > 3% & CFO 97.5m > Net Income -64.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.9m) vs 12m ago 1.54% < -2% |
| Gross Margin: 58.23% > 18% (prev 0.53%; Δ 5770 % > 0.5%) |
| Asset Turnover: 62.98% > 50% (prev 47.80%; Δ 15.19% > 0%) |
| Interest Coverage Ratio: -103.9 > 6 (EBITDA TTM -30.3m / Interest Expense TTM 547.0k) |
Altman Z'' 10.00
| A: 0.42 (Total Current Assets 674.0m - Total Current Liabilities 143.8m) / Total Assets 1.27b |
| B: 0.74 (Retained Earnings 936.8m / Total Assets 1.27b) |
| C: -0.05 (EBIT TTM -56.8m / Avg Total Assets 1.25b) |
| D: 5.36 (Book Value of Equity 937.0m / Total Liabilities 174.9m) |
| Altman-Z'' Score: 10.47 = AAA |
Beneish M -3.13
| DSRI: 0.88 (Receivables 64.5m/54.5m, Revenue 784.8m/584.4m) |
| GMI: 0.92 (GM 58.23% / 53.42%) |
| AQI: 0.92 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 1.34 (Revenue 784.8m / 584.4m) |
| TATA: -0.13 (NI -64.9m - CFO 97.5m) / TA 1.27b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of SLAB shares?
As of February 07, 2026, the stock is trading at USD 206.50 with a total of 1,745,534 shares traded.
Over the past week, the price has changed by +44.96%, over one month by +39.06%, over three months by +58.54% and over the past year by +40.09%.
Over the past week, the price has changed by +44.96%, over one month by +39.06%, over three months by +58.54% and over the past year by +40.09%.
Is SLAB a buy, sell or hold?
Silicon Laboratories has received a consensus analysts rating of 3.73.
Therefor, it is recommend to hold SLAB.
- StrongBuy: 3
- Buy: 2
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SLAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 152.2 | -26.3% |
| Analysts Target Price | 152.2 | -26.3% |
| ValueRay Target Price | 229.8 | 11.3% |
SLAB Fundamental Data Overview February 05, 2026
P/E Forward = 53.1915
P/S = 6.0424
P/B = 4.4043
P/EG = 3.0343
Revenue TTM = 784.8m USD
EBIT TTM = -56.8m USD
EBITDA TTM = -30.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -364.2m USD (from netDebt column, last quarter)
Enterprise Value = 4.04b USD (4.49b + (null Debt) - CCE 443.6m)
Interest Coverage Ratio = -103.9 (Ebit TTM -56.8m / Interest Expense TTM 547.0k)
EV/FCF = 54.97x (Enterprise Value 4.04b / FCF TTM 73.6m)
FCF Yield = 1.82% (FCF TTM 73.6m / Enterprise Value 4.04b)
FCF Margin = 9.38% (FCF TTM 73.6m / Revenue TTM 784.8m)
Net Margin = -8.27% (Net Income TTM -64.9m / Revenue TTM 784.8m)
Gross Margin = 58.23% ((Revenue TTM 784.8m - Cost of Revenue TTM 327.8m) / Revenue TTM)
Gross Margin QoQ = 63.44% (prev 57.78%)
Tobins Q-Ratio = 3.19 (Enterprise Value 4.04b / Total Assets 1.27b)
Interest Expense / Debt = unknown (Interest Expense -214.0k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -44.9m (EBIT -56.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.69 (Total Current Assets 674.0m / Total Current Liabilities 143.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 12.04 (negative EBITDA) (Net Debt -364.2m / EBITDA -30.3m)
Debt / FCF = -4.95 (Net Debt -364.2m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.21% (Net Income -64.9m / Total Assets 1.27b)
RoE = -6.05% (Net Income TTM -64.9m / Total Stockholder Equity 1.07b)
RoCE = -5.05% (EBIT -56.8m / Capital Employed (Total Assets 1.27b - Current Liab 143.8m))
RoIC = -4.21% (negative operating profit) (NOPAT -44.9m / Invested Capital 1.07b)
WACC = 12.30% (E(4.49b)/V(4.49b) * Re(12.30%) + (debt-free company))
Discount Rate = 12.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.67%
[DCF Debug] Terminal Value 53.62% ; FCFF base≈73.6m ; Y1≈48.3m ; Y5≈22.0m
Fair Price DCF = 18.75 (EV 251.9m - Net Debt -364.2m = Equity 616.1m / Shares 32.9m; r=12.30% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.57 | EPS CAGR: -20.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: -35.41 | Revenue CAGR: -3.05% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=-0.000 | Revisions Net=+4 | Analysts=10
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=+0.015 | Revisions Net=+1 | Growth EPS=+198.6% | Growth Revenue=+17.9%
P/S = 6.0424
P/B = 4.4043
P/EG = 3.0343
Revenue TTM = 784.8m USD
EBIT TTM = -56.8m USD
EBITDA TTM = -30.3m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -364.2m USD (from netDebt column, last quarter)
Enterprise Value = 4.04b USD (4.49b + (null Debt) - CCE 443.6m)
Interest Coverage Ratio = -103.9 (Ebit TTM -56.8m / Interest Expense TTM 547.0k)
EV/FCF = 54.97x (Enterprise Value 4.04b / FCF TTM 73.6m)
FCF Yield = 1.82% (FCF TTM 73.6m / Enterprise Value 4.04b)
FCF Margin = 9.38% (FCF TTM 73.6m / Revenue TTM 784.8m)
Net Margin = -8.27% (Net Income TTM -64.9m / Revenue TTM 784.8m)
Gross Margin = 58.23% ((Revenue TTM 784.8m - Cost of Revenue TTM 327.8m) / Revenue TTM)
Gross Margin QoQ = 63.44% (prev 57.78%)
Tobins Q-Ratio = 3.19 (Enterprise Value 4.04b / Total Assets 1.27b)
Interest Expense / Debt = unknown (Interest Expense -214.0k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -44.9m (EBIT -56.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.69 (Total Current Assets 674.0m / Total Current Liabilities 143.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 12.04 (negative EBITDA) (Net Debt -364.2m / EBITDA -30.3m)
Debt / FCF = -4.95 (Net Debt -364.2m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.21% (Net Income -64.9m / Total Assets 1.27b)
RoE = -6.05% (Net Income TTM -64.9m / Total Stockholder Equity 1.07b)
RoCE = -5.05% (EBIT -56.8m / Capital Employed (Total Assets 1.27b - Current Liab 143.8m))
RoIC = -4.21% (negative operating profit) (NOPAT -44.9m / Invested Capital 1.07b)
WACC = 12.30% (E(4.49b)/V(4.49b) * Re(12.30%) + (debt-free company))
Discount Rate = 12.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.67%
[DCF Debug] Terminal Value 53.62% ; FCFF base≈73.6m ; Y1≈48.3m ; Y5≈22.0m
Fair Price DCF = 18.75 (EV 251.9m - Net Debt -364.2m = Equity 616.1m / Shares 32.9m; r=12.30% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.57 | EPS CAGR: -20.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: -35.41 | Revenue CAGR: -3.05% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=-0.000 | Revisions Net=+4 | Analysts=10
EPS next Year (2026-12-31): EPS=2.71 | Chg30d=+0.015 | Revisions Net=+1 | Growth EPS=+198.6% | Growth Revenue=+17.9%